AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2014
Aug 4, 2014
31982_dirs_2014-08-04_0621ff68-c3ba-46bf-9a1c-f1f3bdd3870f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-07-31
Reporting Person: Herrmann John A III (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-31 | Common Stock | P | 8950 | $2.28 | Acquired | 16614 | Direct |
Footnotes
F1: Includes 8,950 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on July 31, 2014.
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26